F
Clovis Oncology, Inc. CLVSQ
OTC PK
Recommendation
--
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
--
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2022 06/30/2022 03/31/2022 12/31/2021 09/30/2021
Revenue -14.78% -10.62% -9.41% -9.58% -2.77%
Total Other Revenue -- -- -- -- --
Total Revenue -14.78% -10.62% -9.41% -9.58% -2.77%
Cost of Revenue -8.53% -4.75% -5.79% -7.40% -0.16%
Gross Profit -16.55% -12.27% -10.44% -10.20% -3.48%
SG&A Expenses -7.57% -10.48% -15.58% -21.66% -19.30%
Depreciation & Amortization 0.00% 0.00% 1.19% 3.75% 6.46%
Other Operating Expenses 124.26% 220.86% 267.99% 292.35% 43.32%
Total Operating Expenses -12.67% -12.56% -18.46% -20.99% -20.59%
Operating Income 11.26% 13.78% 23.67% 27.20% 29.28%
Income Before Tax 15.80% 15.18% 23.15% 28.35% 18.44%
Income Tax Expenses 26.23% 26.38% 36.54% 26.33% -123.24%
Earnings from Continuing Operations 15.78% 15.16% 23.13% 28.35% 19.11%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 15.78% 15.16% 23.13% 28.35% 19.11%
EBIT 11.26% 13.78% 23.67% 27.20% 29.28%
EBITDA 11.31% 13.97% 24.35% 28.06% 30.14%
EPS Basic 35.68% 37.16% 43.06% 48.16% 46.02%
Normalized Basic EPS 28.11% 32.25% 39.68% 44.30% 50.61%
EPS Diluted 35.68% 37.16% 43.12% 48.20% 46.04%
Normalized Diluted EPS 28.11% 32.25% 39.68% 44.30% 50.61%
Average Basic Shares Outstanding 28.96% 33.76% 34.29% 37.19% 45.87%
Average Diluted Shares Outstanding 28.96% 33.76% 34.29% 37.19% 45.87%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings